Expedited SSC testing, defined here to mean diagnostic results within 48 hours of when a sample is received, is available from certain laboratories, including Duke and Mayo Clinic. Other laboratories may offer expedited SSC testing services, and turnaround times may vary. The ultimate choice of laboratory is solely between the patient and the treating physician. Please contact your preferred laboratory to verify whether expedited testing is available and to confirm turnaround time.
If you are aware of another laboratory that provides expedited SSC testing or would like to have your laboratory included on this brochure, please email medical_affairs@sentynl.com. Sentynl does not subsidize any tests nor does it have any financial interests in the laboratories listed.
What are the symptoms of MoCD Type A?
Disorders of sulfite intoxication, including MoCD Type A, are primarily characterized by neurological symptoms1
Neurological symptoms may present acutely in the neonatal period or gradually later in infancy and early childhood.2
Clinical Presentation
Symptoms that present acutely in the neonatal period include2,3:
References: 1. Mechler K, Mountford W, Hoffmann G, Ries M. Ultra-orphan diseases: a quantitative analysis of the natural history of molybdenum cofactor deficiency. Genet Med. 2015;17(12):965-970. 2. Misko A, Liang Y, Kohl J, Eichler F. Delineating the phenotypic spectrum of sulfite oxidase and molybdenum cofactor deficiency. Neurol Genet. 2020;6(4):1-10. 3. Spiegel R, Schwahn BC, Squires L, Confer N. Molybdenum cofactor deficiency: a natural history. J Inherit Metab Dis. 2022;45(3):456-469. 4. Ferreira CR, van Karnebeek CDM. Inborn errors of metabolism. Handb Clin Neurol. 2019;162:449-481.
For more information, contact Medical Affairs at Sentynl Therapeutics at 1-888-507-5206